AtriCure (ATRC) Misses Q4 EPS by 14c, Revenues Miss; Offers 1Q & FY21 EPS/Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ACN
3. NVDA
4. GOOGL
5. MU
6. DFTX
7. USO
8. APGE
9. ABBV
10. NAVN

Go back to AtriCure (ATRC) Misses Q4 EPS by 14c, Revenues Miss; Offers 1Q & FY21 EPS/Revenue Guidance Below Consensus

AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

February 23, 2021 4:01 PM EST

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation... More